Zurich Cantonal Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,170
| Closed | -$539K | – | 2685 |
|
|
2024
Q2 | $539K | Hold |
13,170
| – | – | ﹤0.01% | 1439 |
|
|
2024
Q1 | $557K | Hold |
13,170
| – | – | ﹤0.01% | 1395 |
|
|
2023
Q4 | $558K | Buy |
13,170
+1,091
| +9% | +$46.3K | ﹤0.01% | 1427 |
|
|
2023
Q3 | $264K | Buy |
12,079
+1,925
| +19% | +$42K | ﹤0.01% | 1799 |
|
|
2023
Q2 | $323K | Hold |
10,154
| – | – | ﹤0.01% | 1635 |
|
|
2023
Q1 | $248K | Hold |
10,154
| – | – | ﹤0.01% | 1739 |
|
|
2022
Q4 | $320K | Buy |
10,154
+3,020
| +42% | +$95.3K | ﹤0.01% | 1529 |
|
|
2022
Q3 | $202K | Hold |
7,134
| – | – | ﹤0.01% | 1751 |
|
|
2022
Q2 | $189K | Hold |
7,134
| – | – | ﹤0.01% | 1823 |
|
|
2022
Q1 | $250K | Buy |
7,134
+1,657
| +30% | +$58.1K | ﹤0.01% | 1754 |
|
|
2021
Q4 | $178K | Buy |
5,477
+2,478
| +83% | +$80.5K | ﹤0.01% | 2149 |
|
|
2021
Q3 | $88K | Buy |
+2,999
| New | +$88K | ﹤0.01% | 2407 |
|